OMNY Health GI data partnership | Outpatient colonoscopy 'skyrockets' | PE bankruptcies explode 112% in 5 years

Why the outpatient colonoscopy market has 'skyrocketed' (Becker’s GI & Endoscopy)

This shift has been advantageous for many ASCs, as the demand for these procedures has continued to rise, especially in the outpatient setting.

Dr. Aja McCutchen: A new startup in women's gut health (The Scope Forward Show/NextServices)

Dive deep with Dr. Aja McCutchen, Co-Founder of OLVI Health, as she unveils her groundbreaking venture into women's gut health.

'Big data' can revolutionize gastroenterology (MDLinx)

These technologies are utilized to improve diagnostics in gastroenterology, especially in areas like colonoscopy, where they help identify polyps.

Balancing hope and reality: The promise and peril of blood-based colorectal cancer screening (STAT)

While blood tests offer greater accessibility and convenience compared to colonoscopies, they primarily focus on detection rather than prevention.

A Gastroenterologist’s Journey to Innovation and Entrepreneurship with Tom Shehab, MD (Healio)

Dr. Tom Shehab's advice and perspectives are crucial for medical professionals considering alternative career paths or looking to invest in and advance GI through innovative solutions.

OMNY Health launches new GI real-world data solutions in partnership with leading US gastroenterology practices (PR Newswire)

This partnership brings over 5,000 GI providers into OMNY’s research network, representing care for more than 10 million patients.

Federal Trade Commission Bans Noncompete Agreements, Urges More Protections for Healthcare Workers (Medscape)

The FTC has voted to ban noncompete agreements, aiming to make it easier for doctors and other healthcare workers to change jobs without leaving their communities and patients behind.

A new capsule for long term monitoring in suspected upper GI-bleeding – first in human use of the HemoPill monitor (Thieme)

The HemoPill monitor is a photometric capsule endoscopy device designed for non-invasive diagnosis and long-term monitoring of potential sources of bleeding in the upper GI tract.  

Psycho-Gastroenterology: Navigating IBS and IBD Through a Neuroscientific Lens (Jamie Mentzer on LinkedIn)

The concept explores the intersection of neuroscience and gastroenterology, focusing on the connections between the brain and the gut.

Freenome to Lay off 20 Percent of Workforce (GenomeWeb)

The cancer screening company is set to cut 20% of workforce after securing $254 million.

Are Direct-to-Consumer Microbiome Tests Clinically Useful? (Medscape)

Direct-to-consumer (DTC) microbiome tests are offered by various companies claiming to improve gut health with personalized treatments based on microbiome analysis.

Private equity bankruptcies in healthcare explode 112% in 5 years (HealthExec) The report indicates a trend of financial instability within firms owned by private equity, with multiple bankruptcies noted from the same firm.

See the 11 mentors voted best in our field (AGA)

The AGA Institute Council Research Mentor Award is given to members who have significantly contributed as mentors in the gastroenterology and hepatology research community.

Doctors are getting on board with genAI, survey shows (Healthcare IT News)

A new survey conducted by Wolters Kluwer Health shows increasing enthusiasm among physicians for generative AI (genAI), with 81% believing it improves care team interactions with patients.

Survey: Impostor Phenomenon, Microaggressions Common in GI (GI & Endoscopy News)

A leadership conference survey for female gastroenterology healthcare professionals revealed that over 92% of respondents experienced microaggressions at work, and more than 88% felt the “impostor phenomenon.”

For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the Scope Forward newsletter.

Get the book: Scope Forward - The Future of Gastroenterology Is Now In Your Hands.